All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
ABBV total return snapshot: ABBV returned +18.95% over the past year and −4.18% YTD, with dividends reinvested. Since Dec. 10, 2012, ABBV is up +951.29% in nominal total return, or +19.07%/yr, and is currently −9.77% below its total-return high on Oct. 1, 2025.
| Mon 2012-12-10💬 to Tue 2026-06-02 |
YTD
Return |
1 Year
Return |
||||
|---|---|---|---|---|---|---|
| ABBV × |
−4.18%
2026-06-02 |
+18.95%
2026-06-02 |
||||
| AbbVie Inc NYSE Common Stock | ||||||
| Mon 2012-12-10💬 to Tue 2026-06-02 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| ABBV × |
+951.29%
+19.07%/yr |
+17.73%/yr
(R2=0.963) |
||||
| AbbVie Inc NYSE Common Stock | ||||||
| Mon 2012-12-10💬 to Tue 2026-06-02 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| ABBV × |
$10,000.00
2012-12-10 |
$105,129.07
2026-06-02 |
||||
| AbbVie Inc NYSE Common Stock | ||||||
| Year | ABBV |
|---|---|
| 2026 (YTD) | −4.18% |
| 2025 | +33.08% |
| 2024 | +18.87% |
| 2023 | −0.23% |
| 2022 | +24.01% |
| 2021 | +32.43% |
| 2020 | +27.72% |
| 2019 | +1.47% |
| 2018 | −0.96% |
| 2017 | +60.07% |
| 2016 | +9.79% |
| 2015 | −6.50% |
| 2014 | +27.92% |
| 2013 | +60.77% |
| 2012 | −2.40% |
| Mon 2012-12-10💬 to Tue 2026-06-02 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| ABBV × |
−9.77%
from 2025-10-01 peak |
−45.09%
2019-08-15 from 2018-01-26 peak |
||||
| AbbVie Inc NYSE Common Stock | ||||||
| Period ending Tue 2026-06-02 |
1
Year |
2
Years |
3
Years |
5
Years |
10
Years |
|
|---|---|---|---|---|---|---|
| ABBV × | +18.95% |
+42.96% +19.52%/yr |
+75.25% +20.56%/yr |
+133.25% +18.46%/yr |
+399.72% +17.46%/yr |
|
| AbbVie Inc NYSE Common Stock | ||||||
